| CAS: | 751475-53-3 | ||||||||
| 分子式: | C29H38FN3O5 | ||||||||
| 分子量: | 527.63 | ||||||||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||
| A960545 | MACKLIN | 阿托帕沙 | 98% | 318元/1mg; 1119元/5mg; 2042元/10mg; 4541元/25mg; 7184元/50mg; | 咨询 | ||||||||||||||||||||||||||||
储存:-20°C, 密封, 干燥 状态:白色到灰白色固体 | |||||||||||||||||||||||||||||||||
| SML3064 | Sigma-Aldrich | Atopaxar hydrobromide | ≥98% (HPLC) | 1572.9元/5 MG; 6314.76元/25 MG; | 咨询 | ||||||||||||||||||||||||||||
产品说明 生化/生理作用 Atopaxar (E5555) is an orally active, potent and selective thrombin receptor (protease-activated receptor; PAR1) antagonist (IC50 = 19 nM/E5555 vs. 490 nM/TRAP against 10 nM haTRAP for PAR-1 binding on human platelet membranes) that inhibits platelet aggregation induced by thrombin or TRAP T (human platelet IC50 = 64/31 nM against 1 u/mL Thrombin/5 μM TRAP; guinea pig IC50 = 13/97 nM against 2 u/mL Thrombin/20 μM TRAP), but not ADP, U46619, collagen, PAR-4ap or PAF. Atopaxar exhibits antithrombotic efficacy in guinea pigs and rats in vivo (10, 30, 100 mg/kg p.o.). 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||